Resistance a major hindrance to chemotherapy in hepatocellular carcinoma: an insight.

about

Resistance a major hindrance to chemotherapy in hepatocellular carcinoma: an insight.

Item

http://www.wikidata.org/entity/Q52345488

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Resistance a major hindrance to chemotherapy in hepatocellular carcinoma: an insight.

@en

Resistance a major hindrance to chemotherapy in hepatocellular carcinoma: an insight.

@nl

type

Item

label

Resistance a major hindrance to chemotherapy in hepatocellular carcinoma: an insight.

@en

Resistance a major hindrance to chemotherapy in hepatocellular carcinoma: an insight.

@nl

prefLabel

Resistance a major hindrance to chemotherapy in hepatocellular carcinoma: an insight.

@en

Resistance a major hindrance to chemotherapy in hepatocellular carcinoma: an insight.

@nl

P1476

Resistance a major hindrance to chemotherapy in hepatocellular carcinoma: an insight

@en

P2093

K Lohitesh

http://www.w3.org/2001/XMLSchema#string

Rajdeep Chowdhury

http://www.w3.org/2001/XMLSchema#string

P2860

p62/Sqstm1 promotes malignancy of HCV-positive hepatocellular carcinoma through Nrf2-dependent metabolic reprogramming

Stem cells, cancer, and cancer stem cells

Profile of tivantinib and its potential in the treatment of hepatocellular carcinoma: the evidence to date

5-fluorouracil: mechanisms of action and clinical strategies

A Phase I dose-escalation study of sibrotuzumab in patients with advanced or metastatic fibroblast activation protein-positive cancer

Expression of the multidrug resistance proteins MRP2 and MRP3 in human hepatocellular carcinoma

Organic anion transporting polypeptides of the OATP/ SLC21 family: phylogenetic classification as OATP/ SLCO superfamily, new nomenclature and molecular/functional properties

Genome-wide analysis of miRNA signature differentially expressed in doxorubicin-resistant and parental human hepatocellular carcinoma cell lines

Potentiating the efficacy of molecular targeted therapy for hepatocellular carcinoma by inhibiting the insulin-like growth factor pathway

Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion

P2888

s12935-018-0538-7

P304

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/S12935-018-0538-7

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Sudeshna Mukherjee

P577

2018-03-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1101630923

http://www.w3.org/2001/XMLSchema#string

P698

29568237

http://www.w3.org/2001/XMLSchema#string

P932

5859782

http://www.w3.org/2001/XMLSchema#string